The Centre for Translational Cancer Research was established in October 2010 to engage and support citywide translational cancer research by linking researchers from multiple disciplines with academic clinicians as an important first step to address the complexity of cancer as a disease. The vision of the Centre for Translational Cancer Research (CTCR) is to develop a leading translational cancer research enterprise, citywide, that will make major positive impacts on the lives of those affected by cancer by addressing “big” cancer questions.
As a result of citywide cancer research strength and researcher links between scientists and clinicians, interdisciplinary teams with a translational focus have developed in the areas of Breast, Head and Neck, Ovarian and Prostate cancer. These pioneering translational cancer research teams provide a platform of proven expertise that will enhance opportunities to establish new research capability aligned with cancer disease sites teams such as Colorectal and Lung. The Centre for Translational Cancer Research will facilitate knowledge transfer between teams to pursue research pertaining to major treatment goals such as early detection, prevention, novel therapies or technology platforms with potential for patient application.
The key priorities of the Centre for Translational Cancer Research are to:
For more information please contact Elizabeth Mazza at email@example.com